Replication-competent viruses for cancer therapy
著者
書誌事項
Replication-competent viruses for cancer therapy
（Monographs in virology, v. 22）
Karger, c2001
- タイトル別名
-
Replication competent viruses for cancer therapy
大学図書館所蔵 件 / 全4件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Current cancer treatment approaches are characterized by very tight therapeutic indices and medical oncologists assign considerable care to treat adverse effects. A newly evolving concept in cancer therapy is the use of viruses. About 40 years ago initial trials based on the use of wild-type virus were not successful due to variable antitumoral effects and toxicity. The increase in our understanding of the molecular biology of malignant cells and viruses has now enabled researchers to design viruses that are capable of selectively destroying cancer cells and spare normal surrounding tissue. Oncolytic viruses either carry defined defects in their genomes which are specifically complemented by cancer cells, allowing their replication; or they are inherently selective for tumor cells. This book is the first to summarize the molecular principles of modern viral therapy for cancer. It reviews many of the replication-competent viruses currently being investigated for therapeutic use including herpes simplex virus, adenovirus, reovirus, parvovirus, vaccinia virus and Newcastle disease virus, and demonstrates how this approach is being translated to the clinic. Illustrating how virus-host interactions can be exploited for therapy, this book opens up new and promising perspectives for the treatment of cancer. It is therefore recommended reading for clinical investigators in the field of oncology, virologists, cancer immunologists and scientists working in regulatory agencies.
目次
- Replication-competent herpes simplex virus vectors for cancer therapy
- dl1520 (ONYX-015) as an antitumour agent
- attenuated replication-competent adenoviruses (ARCA) for prostate cancer - CV706 to CV787
- reovirus as a potential anticancer therapeutic
- autonomous parvoviruses
- vaccinia virus
- replication-competent, oncolytic Newcastle disease virus for cancer therapy.
「Nielsen BookData」 より